Neoplasms in patients from the DBAR
DBAR UPIN . | Cancer diagnosis . | Sex . | Age at diagnosis, y . | DBA status at cancer diagnosis . | Outcome . | Gene . |
---|---|---|---|---|---|---|
0009-200 | Adenocarcinoma of the colon | M | 43 | Unknown | Alive | Not tested |
0300-104 | Adenocarcinoma of the colon | F | 34 | TD | Died | RPS19 |
0438-200 | Adenocarcinoma of the colon | F | 49 | SD | Alive | Negative |
0143-200 | Osteogenic sarcoma | M | 22 | TD, A, rhGH | Died, sepsis | Not tested |
0354-200 | Osteogenic sarcoma | F | 13 | TD, A | Died, metastatic disease | Not tested |
0185-200 | Soft tissue sarcoma | M | 30 | TD | Died, metastatic disease | Not tested |
0438-200 | Breast cancer | F | 43 | SD | Alive | Negative |
0458-200 | Breast cancer | F | 34 | Remission | Alive | RPS19 |
0416-102 | Uterine cancer | F | 64 | Never treated | Died, metastatic disease | RPS19 |
0534-200 | Cervical cancer | F | 27 | TD | Alive | RPS19 |
0109-101 | Testicular cancer | M | 62 | Remission | Alive | RPL35a |
0024-200 | Choroid meningioma of lung | F | 21 | TD | Alive | RPS19 |
0245-002 | SCC oral | F | 69 | TD, Steroids | Died | RPL11 |
0245-102 | SCC vaginal | F | 45 | Tx with chemotherapy only | Alive | RPL11 |
0025-102 | Melanoma | F | 50 | On no treatment | Alive | RPL5 |
0365-200 | Non-Hodgkin lymphoma | M | 41 | TD | Alive | RPL5 |
0364-101 | AML | M | 45 | On no treatment | Died, sepsis | Negative |
0387-200 | AML | M | 44 | SD | Died, chemotherapy/BMT, PD | Not tested |
0100-200 | MDS | M | 17 | TD | Died, sepsis | Not tested |
0308-200 | MDS | M | 2 | SD | Alive | Not tested |
0364-101 | MDS | M | 45 | On no treatment | Died (progressed to AML) | Negative |
0438-200 | MDS | F | 51 | TD, on azathioprine | Alive | Negative |
0200-200* | Osteogenic sarcoma | M | 4 | TD, s/p BMT, rhGH | Died, metastatic disease | Not tested |
0260-200* | Rectal cancer | F | 28 | s/p BMT | Alive | Not tested |
0277-101* | Basal cell cancer | M | 30 | SD | Alive | Not tested |
DBAR UPIN . | Cancer diagnosis . | Sex . | Age at diagnosis, y . | DBA status at cancer diagnosis . | Outcome . | Gene . |
---|---|---|---|---|---|---|
0009-200 | Adenocarcinoma of the colon | M | 43 | Unknown | Alive | Not tested |
0300-104 | Adenocarcinoma of the colon | F | 34 | TD | Died | RPS19 |
0438-200 | Adenocarcinoma of the colon | F | 49 | SD | Alive | Negative |
0143-200 | Osteogenic sarcoma | M | 22 | TD, A, rhGH | Died, sepsis | Not tested |
0354-200 | Osteogenic sarcoma | F | 13 | TD, A | Died, metastatic disease | Not tested |
0185-200 | Soft tissue sarcoma | M | 30 | TD | Died, metastatic disease | Not tested |
0438-200 | Breast cancer | F | 43 | SD | Alive | Negative |
0458-200 | Breast cancer | F | 34 | Remission | Alive | RPS19 |
0416-102 | Uterine cancer | F | 64 | Never treated | Died, metastatic disease | RPS19 |
0534-200 | Cervical cancer | F | 27 | TD | Alive | RPS19 |
0109-101 | Testicular cancer | M | 62 | Remission | Alive | RPL35a |
0024-200 | Choroid meningioma of lung | F | 21 | TD | Alive | RPS19 |
0245-002 | SCC oral | F | 69 | TD, Steroids | Died | RPL11 |
0245-102 | SCC vaginal | F | 45 | Tx with chemotherapy only | Alive | RPL11 |
0025-102 | Melanoma | F | 50 | On no treatment | Alive | RPL5 |
0365-200 | Non-Hodgkin lymphoma | M | 41 | TD | Alive | RPL5 |
0364-101 | AML | M | 45 | On no treatment | Died, sepsis | Negative |
0387-200 | AML | M | 44 | SD | Died, chemotherapy/BMT, PD | Not tested |
0100-200 | MDS | M | 17 | TD | Died, sepsis | Not tested |
0308-200 | MDS | M | 2 | SD | Alive | Not tested |
0364-101 | MDS | M | 45 | On no treatment | Died (progressed to AML) | Negative |
0438-200 | MDS | F | 51 | TD, on azathioprine | Alive | Negative |
0200-200* | Osteogenic sarcoma | M | 4 | TD, s/p BMT, rhGH | Died, metastatic disease | Not tested |
0260-200* | Rectal cancer | F | 28 | s/p BMT | Alive | Not tested |
0277-101* | Basal cell cancer | M | 30 | SD | Alive | Not tested |
DBA indicates Diamond Blackfan anemia; DBAR, Diamond Blackfan Anemia Registry; UPIN, unique patient identification number; M, male; F, female; TD, transfusion dependent; SD, steroid dependent; A, androgen therapy; rhGH, recombinant human growth hormone; SCC, squamous cell carcinoma; s/p BMT, status post bone marrow (stem cell) transplantation; Tx, transfusion; and PD, progressive disease.
Excluded from analysis.